Product Information
QC LONG ACT COUGH 15 MG SOFTGL is a generic product labeled by Chain Drug Marketing Association, priced at $0.1217 per EA under NDC 83324030320. Its NADAC has been published 95 times since Dec 11, 2024.
Strength
15 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324030320
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/16/2024
Pharmacological Classes
Price Statistics
The NADAC for QC LONG ACT COUGH 15 MG SOFTGL has been published 95 times since Dec 11, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1217 per EA |
|---|---|
| All-time high | $0.1234 (Dec 11, 2024) |
| All-time low | $0.1020 (Dec 17, 2025) |
| 52-week high | $0.1217 |
| 52-week low | $0.1020 |
| Median price | $0.1094 |
| Average price | $0.1113 |
| Largest weekly change | +5.7% (May 20, 2026) |
| Weeks tracked | 95 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan hydrobromide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan hydrobromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC LONG ACT COUGH 15 MG SOFTGL?
The current National Average Drug Acquisition Cost (NADAC) for QC LONG ACT COUGH 15 MG SOFTGL, manufactured by Chain Drug Marketing Association, is $0.1217 per EA (NDC 83324030320), effective Sep 30, 2026.
How has the price of QC LONG ACT COUGH 15 MG SOFTGL changed over time?
Over the history we have for it, the NADAC for QC LONG ACT COUGH 15 MG SOFTGL has held within roughly two percent of its current level. It has been tracked across 95 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for QC LONG ACT COUGH 15 MG SOFTGL?
Since Dec 11, 2024, the NADAC for QC LONG ACT COUGH 15 MG SOFTGL has ranged from a low of $0.1020 (Dec 17, 2025) to a high of $0.1234 (Dec 11, 2024), with a median of $0.1094 per EA.
Are there cheaper alternatives to QC LONG ACT COUGH 15 MG SOFTGL?
No other NADAC-published product currently shares the active ingredient and strength of QC LONG ACT COUGH 15 MG SOFTGL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC LONG ACT COUGH 15 MG SOFTGL?
QC LONG ACT COUGH 15 MG SOFTGL (NDC 83324030320) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.